Related references
Note: Only part of the references are listed.Enhanced Bacteremia in Human Factor H Transgenic Rats Infected by Neisseria meningitidis
David M. Vu et al.
INFECTION AND IMMUNITY (2012)
Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein
Serena Giuntini et al.
INFECTION AND IMMUNITY (2012)
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
Maria Elena Santolaya et al.
LANCET (2012)
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
Peter C. Richmond et al.
LANCET INFECTIOUS DISEASES (2012)
Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: An investigational vaccine component against Neisseria meningitidis
Angela Martino et al.
VACCINE (2012)
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
Davide Serruto et al.
VACCINE (2012)
Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis
Bas van de Waterbeemd et al.
VACCINE (2012)
Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis
J. Marzoa et al.
VACCINE (2012)
Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac
Francois Caron et al.
VACCINE (2012)
Study designs for the nonclinical safety testing of new vaccine products
Roy Forster
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants
Peter van der Ley et al.
HUMAN VACCINES (2011)
Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding
Serena Giuntini et al.
INFECTION AND IMMUNITY (2011)
A Meningococcal Factor H Binding Protein Mutant That Eliminates Factor H Binding Enhances Protective Antibody Responses to Vaccination
Peter T. Beernink et al.
JOURNAL OF IMMUNOLOGY (2011)
Experimental Meningococcal Sepsis in Congenic Transgenic Mice Expressing Human Transferrin
Marek Szatanik et al.
PLOS ONE (2011)
Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination
Helen C. Koenig et al.
VACCINE (2011)
Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
Richard Arnold et al.
VACCINE (2011)
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys
Oliver Koeberling et al.
VACCINE (2011)
An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups
Valerian B. Pinto et al.
VACCINE (2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
P. B. Keiser et al.
VACCINE (2011)
Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid A Acylation Mutants
Mark B. Stoddard et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter
Francesca Oriente et al.
JOURNAL OF BACTERIOLOGY (2010)
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
John Donnelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process
Bas van de Waterbeemd et al.
VACCINE (2010)
Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media
Nikos Tsolakos et al.
VACCINE (2010)
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
Marzia M. Giuliani et al.
VACCINE (2010)
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
Wendell D. Zollinger et al.
VACCINE (2010)
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Han-Qing Jiang et al.
VACCINE (2010)
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Caroline L. Trotter et al.
EXPERT REVIEW OF VACCINES (2009)
Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
Dan M. Granoff et al.
INFECTION AND IMMUNITY (2009)
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Muriel C. Schneider et al.
NATURE (2009)
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
Carl E. Frasch et al.
VACCINE (2009)
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen
Jo Anne Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate
Maite Delgado et al.
VACCINE (2007)
Transgenic mice expressing human transferrin as a model for meningococcal infection
Maria-Leticia Zarantonelli et al.
INFECTION AND IMMUNITY (2007)
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis
Vincent E. Weynants et al.
INFECTION AND IMMUNITY (2007)
TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A
Susu Zughaier et al.
VACCINE (2007)
Safety review:: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease
H. Nokleby et al.
VACCINE (2007)
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
Germie P. J. M. van den Dobbelsteen et al.
VACCINE (2007)
Imaging of Disease Dynamics during Meningococcal Sepsis
Hong Sjolinder et al.
PLOS ONE (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effect of Neisseria meningitidis fur mutations on global control of gene transcription
I Delany et al.
JOURNAL OF BACTERIOLOGY (2006)
Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis
HE Humphries et al.
VACCINE (2006)
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254
C Vipond et al.
PROTEOMICS (2006)
Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B
DMB Post et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: Developmental chemistry and investigation of immunological responses following immunization of mice and rabbits
AD Cox et al.
VACCINE (2005)
Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits
DR Shoemaker et al.
INFECTION AND IMMUNITY (2005)
Identification of novel antigens that protect against systemic meningococcal infection
YH Sun et al.
VACCINE (2005)
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination
M Fisseha et al.
INFECTION AND IMMUNITY (2005)
Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules
CAC Gioia et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles
A Gorringe et al.
VACCINE (2005)
Experimental disease models for the assessment of meningococcal vaccines
AR Gorringe et al.
VACCINE (2005)
Characterization of the Protein Content of a Meningococcal Outer Membrane Vesicle Vaccine by Polyacrylamide Gel Electrophoresis and Mass Spectrometry
Caroline Vipond et al.
HUMAN VACCINES (2005)
International validation of novel pyrogen tests based on human monocytoid cells
S Hoffmann et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis
T Guthrie et al.
INFECTION AND IMMUNITY (2004)
Iron transport systems in Neisseria meningitidis
D Perkins-Balding et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines
C Arigita et al.
VACCINE (2004)
Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice
LO Fukasawa et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live meningococci
YW Li et al.
INFECTION AND IMMUNITY (2004)
A rapid 'one-plate' in vitro test for pyrogens
S Poole et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes
C Arigita et al.
VACCINE (2003)
Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection
D West et al.
INFECTION AND IMMUNITY (2001)
Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis
C Jansen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Share Paper
